Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity

Yiran Zhu, Yong Lu

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e1756
Journal	Clinical and translational medicine
Volume	14
Issue number	7
DOIs	https://doi.org/10.1002/ctm2.1756
State	Published - Jul 4 2024

Keywords

@article{e68e29e89d144136b30bca79b10be961,

title = "Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity",

keywords = "Clofazimine/therapeutic use, Humans, Immunotherapy/methods, Neoplasms/drug therapy",

author = "Yiran Zhu and Yong Lu",

year = "2024",

month = jul,

day = "4",

doi = "10.1002/ctm2.1756",

language = "English (US)",

volume = "14",

pages = "e1756",

journal = "Clinical and translational medicine",

issn = "2001-1326",

publisher = "Wiley",

number = "7",

}

TY - JOUR

T1 - Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity

AU - Zhu, Yiran

AU - Lu, Yong

PY - 2024/7/4

Y1 - 2024/7/4

KW - Clofazimine/therapeutic use

KW - Humans

KW - Immunotherapy/methods

KW - Neoplasms/drug therapy

U2 - 10.1002/ctm2.1756

DO - 10.1002/ctm2.1756

M3 - Comment/debate

C2 - 38965409

SN - 2001-1326

VL - 14

SP - e1756

JO - Clinical and translational medicine

JF - Clinical and translational medicine

IS - 7

ER -